Conference
Bevacizumab (Bev)-based therapy for patients (pts) with colorectal cancer (CRC): McGill University and Segal Cancer Centre experience.
Authors
Wasserman DW; Bouganim N; Batist G; Metrakos P; Chaudhury P; Hassanain M; Kavan P
Volume
29
Pagination
pp. e14158-e14158
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.e14158
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X